Hepatological Impact of Current Gene Therapy Products – Where Do We Stand & What Lies Ahead?

Time: 11:30 am
day: Day One

Details:

  • Gene therapy related hepatic inflammation – what causes it and what to do
  • Gene therapy and liver cancer, is there a real risk and how should it be managed
  • How should we assess liver function before and after gene therapy

Speakers: